Studies of Product Structure Adjustment Routes for Chinas Pharmaceutical Industry: A View From the New Healthcare Reform Targets

Conclusion: The fundamental drug system and medical insurance system, which the New Healthcare Reform focuses upon, are closely related to the pharmaceutical product structure. For entities in which structural adjustment is not autonomous, changes can be achieved through sound coordination between organizational structure, technical structure, and repeated evaluation of consistency of drug product quality and overseas technical license.
Source: Therapeutic Innovation and Regulatory Science - Category: Drugs & Pharmacology Authors: Tags: Global Perspectives Source Type: research